Has Aaron Smith, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,964 in general payments to Aaron Smith, MD across 93 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Aaron Smith, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Aaron Smith, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Aaron Smith, MD

Urology · Great Neck, NYNPI 1942707146

Payments from drug & device makers

$4,964in general payments, 2019–2025

Across 93 payments — averaging $53.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$3K
Coloplast$2K
Medtronic$108
Endo Pharmaceuticals Inc.$108
Antares Pharma, Inc.$50

What the payments were for

Travel & lodging$1,64233%
Food & beverage$3,32267%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	47	$2,693
Coloplast	42	$2,004
Medtronic	2	$108
Endo Pharmaceuticals Inc.	1	$108
Antares Pharma, Inc.	1	$50

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

TITAN$1,366
AMS 700$114
XIAFLEX$108

How this compares

$4,964 in reported general payments places this provider in the 60th percentile of 952 urology providers in New York.

See all urology providers in New York →

Medicare billing

Part B allowed, 2024

$19,634

Medicare patients

Services billed

197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Testosterone Cypionate	11	$593
Tamsulosin Hcl	39	$591
Finasteride	15	$173
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	18	$91
Meloxicam	11	$33
Oxycodone Hcl	12	$19

Paid to pharmacies, not to this prescriber.

Other urology in Great Neck

Christopher PieczonkaSyracuse$31.2M
Guarionex DecastroNew York$5.7M
Mitchell EfrosGarden City$4.2M
James McKiernanNew York$4.1M
William HuangNew York$3.9M
Jed KaminetskyMiddle Village$3.5M
Evan GoldfischerPoughkeepsie$3.1M
Gennady BratslavskySyracuse$2.5M
Ashutosh TewariNew York$2.5M
Manish ViraNew Hyde Park$2.1M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →